THE DONOWAY CENTER

Pancreatic NanoKnife Tumor Ablation for Advanced and Oligo-Metastatic Pancreatic Cancer

If you are being treated for advanced or oligometastatic pancreatic cancer you may want to contact Dr. Robert Donoway at ATLAS ONCOLOGY in Hollywood, Florida.

Dr Donoway is using multi-modality therapy combining Pancreatic NanoKnife Tumor Ablation with chemo-immunoradio therapy to treat advanced stage cancer patients from around the world after they have stopped responding to standard of care therapy and have been left with few options for further treatment.

With over 32 years of experience performing pancreatic surgery in south Florida, Dr Donoway recognized that because of late diagnosis, up to 85% of patients treated for pancreatic cancer already had metastatic disease at the time of diagnosis. This fact limited the benefit many patients might receive from pancreatic surgery, which is problematic as surgery has been long held to be the only reproduceable therapy for cure; whereas in reality surgery is currently more likely Palliative in almost 80% of the cases.

Recent evidence shows that when even advanced disease is treated aggressively in an integrated approach, incorporating NanoKnife surgery with chemotherapy and now supplemented with immunotherapy, long-term survivorship can be achieved, especially when compared to chemotherapy alone.

Dr Donoway has been a pioneer in the use of pancreatic NanoKnife, especially for complex cases. During the past decade, patients from around the world have traveled to benefit from this groundbreaking treatment by Dr Donoway, which is FDA approved. Dr Donoway also treats other advanced cancers, such as liver, Breast, and sarcomas, using NanoKnife Surgery based on its FDA approved guidelines. Patients experience a brief recovery, which means the patient can start chemotherapy and radiation that much sooner.

Dr Donoway feels that “we are long overdue to revise our approach to treating Pancreatic Ca. The treatment history been largely unchanged for over 80 years and has just broken the 10% five year survivorship barrier. Only thru thinking outside the box will we accomplish the positive. Otherwise, all we’re doing is confirming Einstein‘s definition of insanity.”

Dr Donoway is involved in ongoing research in identifying the best chemo-immuno therapy and sequencing to be used along with Pancreatic nanoKnife/IRE . Dr Donoway states, “the results so far have been very encouraging and we have begun using it for other select cancers. Among his longest survivors are now patients over nine years without evidence of cancer recurrence. In the past, without IRE they would have lived a little over a year, and so this technique opens a whole new avenue for treating those eligible patients in a more targeted fashion.”

Dr Donoway has presented his results of pancreatic ablation at the recent annual meeting of the American Pancreatic Association. For more information about Dr Donoway and the pancreatic IRE/NanoKnife program call 954-986-6366 or visit www.atlasoncology.com

Robert B. Donoway, M.D., F.A.C.S., F.S.S.O.

Surgical Oncology & Pancreatic Surgical Oncology

Specializing in Cancer of the Pancreas, Liver, GI Tract, Sarcoma, Adrenal, Thyroid, Parathyroid, and Melanoma. Laparoscopic and Image Guided Cancer Surgery, IRE/NanoKnife for NonResectable Pancreatic and Liver Cancer.

Dr. Robert Donoway is a Board Certified Sloan Kettering trained Pancreatic surgical oncologist, who received his MD and surgical training at the University of Pennsylvania. At Sloan Kettering he was the General Motors Pancreatic Cancer Research Fellow. Dr Donoway is a former Director of the Memorial Regional Cancer Center (now the Memorial Cancer Institute) and Chairman of the Cancer committee for the Memorial Healthcare System as well as a former Chief of Surgery and Surgical Oncology at Memorial Regional Hospital in Hollywood, South Florida.

Dr Donoway served on the Board of the American Cancer Society and Gildas club. He has also served as past president of the American Cancer Society Broward chapter and serves on the board of trustees of the Ancient Spanish Monastery.

Dr Donoway is active in the The American and International Hepato-Pancreatico-Biliary Associations, The Pancreas Club, Society of Surgical Oncology and the American Pancreatic Association. His accomplishments include being the first surgeon in Florida to perform radio frequency ablation as well as laparoscopic major liver resection. He is the former recipient of the South Florida Health Award for use of micro-endoscopy for the detection of early stage breast cancer.

Dr Donoway has been repeatedly named to Top Doctor‘s in America by Castle Connolly. Dr Donoway is one of only a few international surgeons performing advanced multi-modal pancreatic and liver ablation therapy for non-resectable tumors.

Robert B. Donoway, M.D., F.A.C.S., F.S.S.O.

Medical

Director,

ATLAS ONCOLOGY:

Institute for Pancreatic Ca IRE NanoKnife Ablation

Former Medical Director Memorial Cancer Center (Now- Memorial Cancer Institute)

Board Certified